Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases. Kabraji S, Ni J, Sammons S, Li T, et al. Clin Cancer Res 2022 Sep 8. pii: 709125. doi: 10.1158/1078-0432.CCR-22-1138.

Read + Share

Amedeo Smart

Independent Medical Education

Kabraji S, Ni J, Sammons S, Li T, et al. Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases. Clin Cancer Res 2022 Sep 8. pii: 709125. doi: 10.1158/1078-0432.CCR-22-1138.
PMID: 36074155